amlodipine has been researched along with HIV Infections in 5 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gynecomastia is known to occur in some men taking an efavirenz-based antiretroviral therapy (ART) regimen." | 7.91 | Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe. ( Chimbetete, C; Shamu, T; Shawarira-Bote, S, 2019) |
| "Gynecomastia is known to occur in some men taking an efavirenz-based antiretroviral therapy (ART) regimen." | 3.91 | Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe. ( Chimbetete, C; Shamu, T; Shawarira-Bote, S, 2019) |
| " We evaluated potential bidirectional pharmacokinetic interactions between calcium channel blockers and coadministered indinavir and ritonavir." | 2.71 | Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. ( Aberg, JA; Fichtenbaum, CJ; Gerber, JG; Glesby, MJ; Grosskopf, N; Hafner, R; Hall, S; Kendall, MA; Zolopa, AR, 2005) |
| ": The risk of drug-drug interactions (DDIs) is elevated in aging people living with HIV (PLWH) because of highly prevalent age-related comorbidities leading to more comedications." | 1.56 | Aging does not impact drug--drug interaction magnitudes with antiretrovirals. ( Battegay, M; Cavassini, M; Courlet, P; Decosterd, L; Marzolini, C; Saldanha, SA; Stader, F; Stoeckle, M, 2020) |
| " As the management of drug-drug interactions (DDIs) constitutes a key aspect of the care of PLWH, the magnitude of pharmacokinetic DDIs between cardiovascular and anti-HIV drugs needs to be more thoroughly characterized." | 1.51 | UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV. ( Alves Saldanha, S; Buclin, T; Cavassini, M; Courlet, P; Csajka, C; Decosterd, LA; Desfontaine, V; Marzolini, C; Spaggiari, D, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shawarira-Bote, S | 1 |
| Shamu, T | 1 |
| Chimbetete, C | 1 |
| Stader, F | 1 |
| Decosterd, L | 1 |
| Stoeckle, M | 1 |
| Cavassini, M | 2 |
| Battegay, M | 1 |
| Saldanha, SA | 1 |
| Marzolini, C | 2 |
| Courlet, P | 2 |
| Spaggiari, D | 1 |
| Desfontaine, V | 1 |
| Alves Saldanha, S | 1 |
| Buclin, T | 1 |
| Csajka, C | 1 |
| Decosterd, LA | 1 |
| Singh, GJ | 1 |
| Jackson, A | 1 |
| D'Avolio, A | 1 |
| Else, L | 1 |
| De Nicolò, A | 1 |
| Bonora, S | 1 |
| Di Perri, G | 1 |
| Khoo, S | 1 |
| Back, D | 1 |
| Moyle, G | 1 |
| Boffito, M | 1 |
| Glesby, MJ | 1 |
| Aberg, JA | 1 |
| Kendall, MA | 1 |
| Fichtenbaum, CJ | 1 |
| Hafner, R | 1 |
| Hall, S | 1 |
| Grosskopf, N | 1 |
| Zolopa, AR | 1 |
| Gerber, JG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Potential Pharmacokinetic Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers[NCT00039975] | Phase 1 | 32 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for amlodipine and HIV Infections
| Article | Year |
|---|---|
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.
Topics: Adolescent; Adult; Amlodipine; Calcium Channel Blockers; Diltiazem; Drug Interactions; Drug Therapy, | 2005 |
4 other studies available for amlodipine and HIV Infections
| Article | Year |
|---|---|
Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe.
Topics: Adult; Alkynes; Amlodipine; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyc | 2019 |
Aging does not impact drug--drug interaction magnitudes with antiretrovirals.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Anti-Retroviral Agents; Antiretroviral Therapy, Highly A | 2020 |
UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.
Topics: Amlodipine; Anti-HIV Agents; Atorvastatin; Chromatography, High Pressure Liquid; Drug Interactions; | 2019 |
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individuals.
Topics: Adult; Amlodipine; Anti-HIV Agents; Antihypertensive Agents; Chromatography, Liquid; Cross-Over Stud | 2014 |